Early Diagnosis of Patients With Mild Cognitive Impairment Through the Parameterization of Functional Tests.
NCT ID: NCT03851198
Last Updated: 2023-12-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2020-04-01
2021-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients with MCI also show greater progression towards dementia, higher mortality and disability, and a greater use of medical care compared to cognitively normal subjects that converts MCI into an important public health problem, which reinforces the need to perfect clinic assessment procedures to improve the early identification of individuals with MCI. Early diagnosis could allow effective medical treatments that prevent or slow the onset of dementia, and could improve the effectiveness of non-pharmacological interventions.
Currently, it can be used an Inertial Sensor and 3D motion capture systems with a camera to analyse kinematics and these instruments are being integrated as a rehabilitation tool in patients. The use of Inertial Sensor and 3D motion capture cameras would help to find fast and cheap assessment methods for professionals.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mild Cognitive Impairment patients
Subjects diagnosed with mild cognitive impairment, who will receive the best treatment of clinical practice, will be recruited. They must be more than 60 years old.
Standard Care or Usual Clinical Practice
The guidelines for the management according to the mild cognitive impairment in primary care will be the treatment guidelines for the Standard Care.
Healthy Subjects/ Match control
Healthy subjects of the same age as people with mild cognitive impairment.
Standard Care or Usual Clinical Practice
The guidelines for the management according to the mild cognitive impairment in primary care will be the treatment guidelines for the Standard Care.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard Care or Usual Clinical Practice
The guidelines for the management according to the mild cognitive impairment in primary care will be the treatment guidelines for the Standard Care.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy subjects and subjects diagnosed with mild cognitive impairment.
* Subjects able of filling out questionnaires and performing functional tests.
Exclusion Criteria
* Participation in an experimental study where they receive a treatment.
* Score on the Mini-Mental State Examination of less than 24.
* Inability to get up from the chair at least 5 times or 30 seconds
* Inability to walk 20 meters.
* Inability to raise up both arms to 90 degrees or lifting 2 kg with the hand.
* Inability to walk independently without a walking assistance device (cane, crutch or walker).
* Patients with prescription of beta-blockers.
* Inability to provide informed consent.
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
King's College London
OTHER
University of Malaga
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Antonio I Cuesta-Vargas
PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Health Science School , University of Malaga
Málaga, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IJFA07
Identifier Type: -
Identifier Source: org_study_id